IgA glycosylation and immune complex formation in IgAN

Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy

(2021) Zina Moldoveanu et al.   JOURNAL OF AUTOIMMUNITY

Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy

(2021) Toshiki Kano et al.   KIDNEY INTERNATIONAL

Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch–Schönlein purpura nephritis

(2020) Hitoshi Irabu et al.   PEDIATRIC RESEARCH

Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy

(2020) Akiko Takahata et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Prevalence, Characteristics, and Outcomes of Incidental IgA Glomerular Deposits in Donor Kidneys

(2020) Lillian W. Gaber et al.   Kidney International Reports

Glycosylation in health and disease

(2019) Colin Reily et al.   Nature Reviews Nephrology

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression

(2019) Dita Maixnerova et al.   PLoS One

The Maintenance of Memory Plasma Cells

(2019) Laleh Khodadadi et al.   Frontiers in Immunology

Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1

(2019) Dana V. Rizk et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6–mediated pathways in IgA nephropathy

(2019) Yuko Makita et al.   KIDNEY INTERNATIONAL

The Role of IgA in the Pathogenesis of IgA Nephropathy

(2019) Martina Perše et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IgA Function in Relation to the Intestinal Microbiota

(2018) Andrew J. Macpherson et al.   Annual Review of Immunology

Secondary IgA nephropathy

(2018) Manish K. Saha et al.   KIDNEY INTERNATIONAL

IgA Responses to Microbiota

(2018) Jeffrey J. Bunker et al.   IMMUNITY

IgA nephropathy: clearance kinetics of IgA-containing immune complexes

(2018) Ann Chen et al.   Seminars in Immunopathology

Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients

(2018) Shigeaki Nakazawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

(2017) Bengt C Fellström et al.   LANCET

GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway

(2017) Krzysztof Kiryluk et al.   PLoS Genetics

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?

(2016) Hitoshi Suzuki et al.   DISEASE MARKERS

IgA nephropathy and infections

(2016) Cristiana Rollino et al.   JOURNAL OF NEPHROLOGY

Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy

(2016) Z. Q. Huang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IgA nephropathy

(2016) Kar Neng Lai et al.   Nature Reviews Disease Primers

Current Understanding of the Role of Complement in IgA Nephropathy

(2015) N. Maillard et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

New developments in the genetics, pathogenesis, and therapy of IgA nephropathy

(2015) Riccardo Magistroni et al.   KIDNEY INTERNATIONAL

The mucosa–kidney axis in IgA nephropathy

(2015) Jürgen Floege et al.   Nature Reviews Nephrology

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy

(2015) Junichi Yasutake et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy

(2014) Yusuke Suzuki et al.   Clinical and Experimental Nephrology

The genetics and immunobiology of IgA nephropathy

(2014) Krzysztof Kiryluk et al.   JOURNAL OF CLINICAL INVESTIGATION

Pathology of IgA nephropathy

(2014) Ian S. D. Roberts   Nature Reviews Nephrology

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy

(2014) Junichiro Nakata et al.   PLoS One

A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases

(2014) Hiroyuki Yanagawa et al.   PLoS One

The Kinetics of Glomerular Deposition of Nephritogenic IgA

(2014) Kenji Yamaji et al.   PLoS One

Latent IgA deposition from donor kidneys does not affect transplant prognosis, irrespective of mesangial expansion

(2013) Tadashi Sofue et al.   CLINICAL TRANSPLANTATION

IgA Nephropathy

(2013) Robert J. Wyatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

IgA Nephropathy: Molecular Mechanisms of the Disease

(2012) Jiri Mestecky et al.   Annual Review of Pathology-Mechanisms of Disease

Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy

(2012) F. Berthoux et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression

(2012) Na Zhao et al.   KIDNEY INTERNATIONAL

The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy

(2012) Houda Tamouza et al.   KIDNEY INTERNATIONAL

Glycosylation of IgA1 and pathogenesis of IgA nephropathy

(2012) Jan Novak et al.   Seminars in Immunopathology

Dysfunctions of the Iga system: a common link between intestinal and renal diseases

(2011) Christina Papista et al.   Cellular & Molecular Immunology

Pathological Role of Tonsillar B Cells in IgA Nephropathy

(2011) Yusuke Suzuki et al.   Clinical & Developmental Immunology

A treatment dilemma in adult immunoglobulin A nephropathy: what is the appropriate target, preservation of kidney function or induction of clinical remission?

(2011) Hirokazu Imai et al.   Clinical and Experimental Nephrology

Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy

(2011) R. Camilla et al.   Clinical Journal of the American Society of Nephrology

The Pathophysiology of IgA Nephropathy

(2011) H. Suzuki et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort

(2011) S. S. Bellur et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy

(2010) Tatsuyuki Inoue et al.   CLINICAL IMMUNOLOGY

Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability

(2010) M. C. Hastings et al.   Clinical Journal of the American Society of Nephrology

Selective IgA Deficiency

(2010) Leman Yel   JOURNAL OF CLINICAL IMMUNOLOGY

Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses

(2010) S. Hapfelmeier et al.   SCIENCE

Sugars and immune complex formation in IgA nephropathy

(2009) Jonathan Barratt et al.   Nature Reviews Nephrology

Effect of Tonsillectomy Plus Steroid Pulse Therapy on Clinical Remission of IgA Nephropathy: A Controlled Study

(2008) H. Komatsu et al.   Clinical Journal of the American Society of Nephrology

Toll-Like Receptor 9 Affects Severity of IgA Nephropathy

(2008) H. Suzuki et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy

(2008) A. G. Gharavi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IgA Glycosylation and IgA Immune Complexes in the Pathogenesis of IgA Nephropathy

(2008) Jan Novak et al.   SEMINARS IN NEPHROLOGY